Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A -related seizure phenotypes-Reference-Cited by-同舟云学术

Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A -related seizure phenotypes

Published:2018-05-11 Issue:6 Volume:59 Page:1154-1165
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

de Lange Iris M.¹^ORCID,Gunning Boudewijn²,Sonsma Anja C. M.¹,van Gemert Lisette³,van Kempen Marjan¹,Verbeek Nienke E.¹,Nicolai Joost³,Knoers Nine V. A. M.¹,Koeleman Bobby P. C.¹,Brilstra Eva H.¹

Affiliation:

1. Department of Medical Genetics; University Medical Center Utrecht; Utrecht University; Utrecht The Netherlands

2. The Epilepsy Institutes of The Netherlands Foundation (SEIN); Zwolle The Netherlands

3. Academical Center of Epileptology; Maastricht and Heeze The Netherlands

Funder

Dutch Epilepsy Foundation

Stichting Vrienden WKZ on behalf of Stichting Panta Rhei

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link